Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

Provectus Biopharmaceuticals Inc. (PVCT)

Add PVCT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Gulfbreeze, Ovidius, buccaneer1961, TOB
Search This Board:
Last Post: 8/31/2014 10:27:18 AM - Followers: 167 - Board type: Free - Posts Today: 0

This board acts as a portal for PVCT investors, and retains the right to refuse service to individuals not in compliance with reasonable, responsible, and intelligible posting practices.

PVCT on YouTube...

Letter from the CEO Craig Dee's

We are a group of dedicated and entrepreneurial scientists, working together for the past 10 years, engaged in developing breakthrough technologies for cancer and other serious diseases. Our primary goal at Provectus is to develop alternative treatments that are safer, more effective, less invasive and more economical than conventional therapies.

Our Provectus Pharmatech division develops ethical pharmaceuticals for oncology and dermatology. Looking first to oncology, our novel drugs are designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing systemic side effects. In particular, our focus is on melanoma, breast and liver cancers – among the most difficult cancers to treat using conventional methods. We are very excited about the Phase I clinical trials of Provecta™ that began in 2005 for melanoma and breast cancer, and we are expanding to include liver cancer patients soon.

Targeting abnormal or diseased cells is also the approach we use in designing proprietary treatments for dermatological diseases, in particular, chronic, severe cases of psoriasis, eczema and acne. We anticipate that Phase II clinical trials of our topical agent Xantryl™ for psoriasis and eczema will begin soon. In addition, certain skin cancers may be targeted and treated more safely and effectively using Xantryl™.

In addition to our core pharmaceutical work, Provectus has developed a number of intellectual properties and technologies in the areas of medical devices and biotechnologies. Rather than dilute the efforts of Pharmatech, we are actively pursuing licensure, co-development, spin-offs and joint ventures of these technologies via our divisions Provectus Devicetech and Provectus Biotech. Devicetech encompasses both cosmetic and therapeutic treatments, with key attention to developing laser-based products to treat melanoma. Biotech is concentrating on producing vaccines to prevent certain cancers and other serious diseases, as well as detecting new viruses that could be associated with the onset of such diseases.

Our fourth division, Pure-ific Corp., is prepped to be sold or spun off to further develop its over-the-counter products. We are introducing professional skincare products for disposable glove users, and novel retail products for personal hygiene. In addition, we will be introducing an OTC product for acne sufferers.

We are proud of our intellectual capital at Provectus. We hold 15 U.S. patents in the pharmaceutical, medical device and biotech fields, with 19 additional patent applications in the works.

Provectus is a significant, emerging player in the huge and growing pharmaceutical industry. We believe in our potential to improve health care worldwide, using breakthrough products that are easy to manufacture and license, and economical to use. We appreciate your interest in our company, and welcome your comments and questions.

Craig Dees, Ph.D., CEO
Provectus Pharmaceuticals

PVCT 6 months chart:

Technical analysis:

PVCT News:



PVCT insiders transactions:


Drug Delivery Technology magazine special feature article "Revisiting Intralesional Delivery of Cancer Treatment", by Provectus CEO Craig Dees, Ph.D., compares Provectus’ novel cancer drugs to current cancer treatments.

May 17, 2007
Professor Peter Hersey, M.D. comments on PV-10 and a patient's response
Professor Peter Hersey, M.D., a professor of oncology at the University of Newcastle and Medical and Research Director of the Newcastle Melanoma Unit, comments on PV-10 and a patient's response.

Video can be viewed here.

This 15-minute clip follows the progress of an 86-year-old man treated with the drug. Prior to his treatment, his melanoma was so unresponsive to the current standard of care, including numerous invasive operations and toxic chemotherapy, that he was given only months to live.

Video can be viewed here.
Contact Info

Telephone: +1 (865) 769-4011
Fax: +1 (865) 769-4013

Mailing Address:
Provectus Pharmaceuticals, Inc.
7327 Oak Ridge Hwy
Knoxville, TN 37931 USA

Transfer Agent:
(i.e. stockholder records, transfer, change of address, etc.)
Atlas Stock Transfer
5899 South State Street, Suite # 24
Murray, UT 84107
Telephone: +1 (801) 266-7151
Fax: +1 (801) 262-0907

Investor Relations:
Joseph Kessler
The Investor Relations Group
11 Stone St., 3rd fl
New York, NY 10004
Telephone: 212-825-3210
Fax: 212-825-3229

Public Relations:
The Investor Relations Group
Janet Vasquez
Telephone: 212-825-3210

Investment Advisor:
Damon Testaverde
Network 1 Financial Securities
Telephone: +1 (800) 205-8031
Share Statistics
45.45 m
35.35 m

Non-Corp. Insider Hold'gs:
22.20% (as of 4/1/07)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
PVCT News: Current Report Filing (8-k) 05/27/2014 03:45:39 PM
PVCT News: Current Report Filing (8-k) 05/23/2014 02:19:35 PM
PVCT News: Current Report Filing (8-k) 05/21/2014 03:32:59 PM
PVCT News: Amended Statement of Changes in Beneficial Ownership (4/a) 05/20/2014 05:20:44 PM
PVCT News: Statement of Changes in Beneficial Ownership (4) 05/20/2014 06:08:15 AM
#3564  Sticky Note Provectus SEC Filings... Gulfbreeze 05/01/14 12:10:06 AM
#3563  Sticky Note PLEASE STICKY THIS INFORMATION laxerpro22 04/30/14 11:21:55 PM
#6443   KPS88 Sorry - ihub dont take Chinese letters. one_would_believe 08/31/14 10:27:17 AM
#6442   Understand. Thanks Vorlon! KPS88 08/31/14 10:07:18 AM
#6441   If the info on the Yahoo PVCT, in Zooker 08/30/14 12:03:10 PM
#6440   From the looks of the post on the vorlon1966 08/30/14 10:12:19 AM
#6439   ???? Don't get it. What am I missing? KPS88 08/30/14 07:59:40 AM
#6438   ??????PVCT one_would_believe 08/30/14 07:04:33 AM
#6437   ??????PVCT one_would_believe 08/30/14 06:44:29 AM
#6436   Thank You Dennis48 for sharing that. I pray Itsallriggedanyways 08/29/14 01:05:56 PM
#6435   Agreed yaboy... the interest of the Chinese in Dennis48 08/29/14 12:03:14 PM
#6434   This stock is a steal at these prices yaboy520 08/29/14 10:17:25 AM
#6433   China knows that it's interest lies in buying Zooker 08/28/14 05:24:52 PM
#6432   Good question. In other industries they often G Bert 08/28/14 01:13:33 PM
#6431   I don't think that word has any meaning vorlon1966 08/28/14 11:16:37 AM
#6430   PVCT 8/34 Apo T. Amin 08/28/14 10:48:59 AM
#6429   But will the Chinese be as "picky" as Zooker 08/27/14 06:18:55 PM
#6428   It can take a month or so....typo. vorlon1966 08/27/14 04:10:24 PM
#6427   I can take a month or so. There vorlon1966 08/27/14 03:47:36 PM
#6426   how long does it take a third party bleach_ 08/27/14 03:22:56 PM
#6425   ...Nice instinct Ebuilder, ....look what PVCT did with 123tom 08/27/14 01:37:09 PM
#6424   Thanks. It's a Uber long hold. 2-3 yr smitter 08/27/14 12:54:30 PM
#6423   I punched out of this one @ $1.03 Ebuilder 08/27/14 12:43:02 PM
#6422   more like, lack of, and there is the bleach_ 08/27/14 11:57:09 AM
#6421   Remember there are still warrants out there. Upside vorlon1966 08/27/14 11:42:57 AM
#6420   Just another day in PVCT land snidely 08/27/14 11:40:15 AM
#6419   Why PVCT being hit? News? Zooker 08/27/14 11:17:39 AM
#6418   Interesting that SA wanted to publish two articles KPS88 08/27/14 09:51:24 AM
#6417   Re: Day Trading...meant over two or so days. KPS88 08/26/14 09:10:20 PM
#6416   What about glyphosate? It's the active ingredient in Round-Up. snidely 08/26/14 08:05:21 PM
#6415   @ i07nyc, yep, thats the kind of thing 123tom 08/26/14 05:51:04 PM
#6414   Elke you should post that pic to your moniker... 123tom 08/26/14 05:38:37 PM
#6413   Your instinct was good i07nyc, PVCT was hitting 123tom 08/26/14 05:24:26 PM
#6412   How do you profit in day trading when tim779 08/26/14 04:24:59 PM
#6411   Interesting post of Trusted Intelligence by Alan Ross: robofat 08/26/14 02:58:05 PM
#6410   Day trade profit taking? KPS88 08/26/14 02:51:22 PM
#6409   Wondering if Sinopharm would be a player in FortStCowboy 08/26/14 01:41:06 PM
#6408   It has been filled already .87 to 1.8 TrendVestor 08/26/14 01:21:08 PM
#6407   TrendVestor --to which gap do your refer? pacificnorthwest1 08/26/14 01:07:56 PM
#6406   also look at MD Anderson Cancer Center.. 400 sboy777 08/26/14 12:21:45 PM
#6405   123tom, you always talk about the cancer machine i07nyc 08/26/14 12:13:04 PM
#6404   123tom ---patiently waiting and ....wondering pacificnorthwest1 08/26/14 11:41:27 AM
#6403   When is that gap gonna get filled:) TrendVestor 08/26/14 09:18:53 AM
#6402   I'm wondering if we're in bear raid territory yet. KPS88 08/26/14 09:01:31 AM
#6401   i wouldnt get too excited. i'm getting that i07nyc 08/26/14 08:56:22 AM
#6400   $1.17 pm!!! mayvid 08/26/14 08:45:51 AM
#6399   I want to look at the chart again.... 123tom 08/25/14 06:56:02 PM
#6398   New post on the Blog under news. An vorlon1966 08/25/14 04:15:54 PM
#6397   Very realistic thoughts Tom. Thanks for the reminder FortStCowboy 08/25/14 02:45:39 PM
#6396   Great day today looks like people reading DD Paulness 08/25/14 02:37:34 PM
#6395   yes, I dont disagree with those thoughts,Fort St, 123tom 08/25/14 02:12:36 PM
#6394   Trying to Anticipate FortStCowboy 08/25/14 02:05:39 PM